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Abstract: Cancer in humans is frequently associated with compartmentalization of body fluids as
a result of sedentary behavior and pharmacological cellular toxicity. Total Body Water (TBW) in the
general population is approximately 55–60% of body weight in adult males and 50–55% in adult
females, while varying significantly in pathological conditions. Exercise is largely recognized as
an important tool to TBW distribution. The purpose of this study was to investigate, for a least
12 months, the impact of physical activity on body water distribution in a sample of cancer patients
and compare their responses to a sample of healthy controls. Cancer patients included 28 clinically
stable female cancer patients diagnosed with breast cancer (aged 59 ± 9 years, weight 70.2 ± 9.9 kg,
and Body Mass Index (BMI 26.7 ± 5.4 kg·m2), who were enrolled in a year-long physical activity
prescription program. The results indicated the absence of significant variations of TBW% between
the cancer patients and controls, however, there was a significant improvement in intracellular water
content (ICW%) at 6 months (T0: 51.1 ± 3.9 vs. T6: 52.4 ± 4.1; p < 0.05) and at T12 (T0: 51.1 ± 3.9 vs.
T12: 53.6 ± 3.1; p < 0.005). In conclusion, in this small sample of cancer survivors, an unsupervised
cancer rehabilitation program reduced the trend towards increased peripheral edema.
Keywords: hydration; cancer; physical activity
1. Introduction
Hydration status is an important clinical consideration in the long-term management of several
chronic diseases and is an important factor controlling cellular protein turnover that may affect oncotic
pressure [1]. Changes in hydrostatic pressure, oncotic pressure, and vascular permeability may result
in abnormal fluid shifts in the body, resulting in altered intra-(ICW) vs. extracellular water (ECW)
concentrations. Increased ECW results in soft tissue swelling due to expansion of the interstitial volume
and is termed edema. Cancer related edema may be a result of altered oncotic pressure or lymphatic
system obstruction. Additionally, cancer treatments often result in reduced patient physical activity,
and increased sedentary behavior and any associated obesity are likely contributors to altered total
body water distribution [2]. In addition, cancer patients with co-morbidities such as hypertension or
diabetes [3] can further contribute to abnormal water distribution, which may lead to further increased
risk of metabolic disease.
Total body water (TBW) (typically 55–60% in men and 50–55% in women) is important in overall
health, but maintaining a ICW:ECW ratio of approximately 3:2, should be the goal in cancer patients.
It is clear that severe dehydration and associated changes in ICW:ECW ratios (water loss of >2% of body
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weight) leads to reduced overall physiologic and cognitive function, while mild dehydration (water
loss <1.5–2% of body weight), often seen in the general population, can increase the risk of edema.
Exercise is largely recognized as an important tool to regulate TBW distribution [4]. It is clear that
a combination of aerobic and resistance training improves global fitness, cardiovascular performance,
and quality of life of cancer patients [5]. It has been recently reported that unsupervised physical
activity at moderate intensity aimed to maintain cardiovascular fitness [6] works well in the cancer
survivor population. However, relatively few data are available about the impact of unsupervised
physical activity programs on TBW distribution in cancer survivors. Therefore, the purpose of this
study is to investigate TBW distribution in a group of breast cancer survivors participating in a cancer
rehabilitation program.
2. Materials and Methods
2.1. Population Studied
Subjects for this study were recruited from a larger cohort of 145 cancer patients and included
a subgroup composed of 28 female subjects with an average age 59 ± 9 years who were previously
diagnosed with cancer and enrolled in our rehabilitation program from 2013 to 2016. Female
breast cancer patients received one line of chemotherapy, in adjuvant or in palliative setting,
and fourteen received a cardiotoxic chemotherapy agent (either anthracyclines or trastuzumab).
There were 20 cases of quadrantectomy and eight mastectomies performed on the female breast
cancer patients. Additionally, the breast cancer (BC) patients underwent conventional adjuvant
chemotherapy including: doxorubicin and cyclophosphamide or cyclophosphamide, methotrexate
and 5-fluorouracile, or 5-fluorouracile, epirubicin, and cyclophosphamide for approximately three
cycles, where one cycle is defined as a–course of therapy in a monthly interval. Ten subjects were
prescribed hormone therapy (aromatase inhibitors) and all BC subjects had radiotherapy.
All subjects were evaluated by an oncologist and then referred to the Sports Medicine Center
of the same university, where further evaluation and screening were completed. Secondary medical
evaluation revealed the absence of any co-morbidities (cardiovascular disease, diabetes mellitus,
metabolic syndrome).
At the initial phase of the study (T0), all subjects were in stable clinical condition, without evidence
of metastatic disease or clinical and instrumental signs of cardiotoxicity. All cancer subjects were
post-chemotherapy treatment for approximately 1–2 years before entry into the program. The cancer
group was matched to healthy subjects free of cardiovascular risk factors (n = 23 subjects; male,
n = 10 (43%) and female, n = 13 (57%), average age 53 ± 13 years), who followed the same physical
activity program. Assessments on all subjects were completed at 0, 6, and 12 months (T0, T6, T12,
respectively). The local ethics committee approved the study and all the patients gave their written
consent to participate in the study.
2.2. Protocol Study
All subjects completed a questionnaire [7] to estimate their daily level of physical activity for
further classification: sedentary or moderately active. The intensity of the daily activities was estimated
in terms of metabolic equivalents (METS) and compared to standard Physical Activity Levels (PALs) [8].
A PAL level of 1.7 METS·day−1 was used as the criteria to categorize sedentary versus active subjects [9].
A periodic supervision of physical activity was possible by the use of recurrent mobile phone calls
during which adherence to the physical activity was monitored by the using of simple questions.
At the first examination (T0), at six months (T6), and at the end of the protocol (T12), stature,
bodyweight, body mass index (BMI), waist and hip circumferences, and hydration status were
determined. Hydration status, including TBW and distribution, was estimated using bioelectrical
impedance analysis (BIA-101, Akern-RJL Systems, Florence, Italy). The measurements were made
under standard conditions at the temperature of 20–24 ◦C, with the patient supine on a plane
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nonconductive surface keeping upper limbs abducted at 30◦ and lower limbs at 45◦, as per the
manufacturer’s instructions.
Each subject then completed a graded exercise test to volitional exhaustion with echocardiography
monitoring. Standard 2D echocardiography (My Lab 50 echocardiograph Esaote-Italy equipped with
a 2.5 MHz probe) was performed and hemodynamic response to exercise was recorded (systolic and
diastolic blood pressure). This non-invasive cardiological evaluation, as echo fast exam, was done
to exclude those subjects with signs of potential heart failure. For this reason, only the 2D echo
standard measures of the systolic and diastolic parameters were performed, with particular attention
to the Ejection Fraction and to exclude the eventual valves dysfunction. No substantial morphological
modifications of the heart’s function were found and for this reason, the echocardiographic data are
not reported. Peak heart rate (HRpeak), blood pressure, and rating of perceived exertion (RPE) was
recorded and used to determine physical activity intensity in the rehabilitation program.
Each subject also performed a six-minute walk test (6 MWT) which was used in subsequent
follow-up testing [10] to evaluate cardiorespiratory improvement. The 6 MWT is both reliable and
valid in the evaluation of chronically diseased patients, especially when paired with the Borg or CR-10
rating of perceived exertion scale [11].
Resistance training exercises were determined based on the results of hand-grip dynamometry
and chair stand tests. In the hand-grip test, the subject holds a dynamometer in the hand to be tested,
with the arm at a right angle and the elbow by the side of the body. When ready, the subject squeezes
the dynamometer with maximum isometric effort, which is maintained for five seconds. The subject is
verbally encouraged to give a maximum effort and the effort is recorded in kilograms.
During the chair stand test, the subject sits in the middle of a stabilized chair, with their feet
shoulder width apart, flat on the floor. The arms are crossed at the wrists and held close to the chest.
From the sitting position, the subject stands completely up, then completely back down for 30 s.
The total number of complete chair stands is recorded.
Exercise interventions were based on the American College of Sports Medicine (ACSM) exercise
guidelines for cancer survivors [8] and individually tailored to each subject based on their graded
exercise tests and strength assessments. Aerobic exercise intensity was prescribed at 60% of
peak heart rate determined from the maximal treadmill test and consisted primarily of walking.
Resistance training consisted of eight exercises targeting major muscle groups, with three sets and
10–15 repetitions, mainly with free weight or using body weight.
The program was 12 months long and consisted of individual physical activity sessions being
completed, unsupervised at home. Subjects were monitored via mobile phone weekly where either
physical activity (completed or not) or nutrition habits were recorded. Follow-up phone contact has
been shown to increase adherence to home-based physical activity programs [12].
All the subjects were instructed to follow a typical Mediterranean diet throughout the study
period, where the whole daily calories were divided in five meals, three main meals and two snacks.
The diet was generally determined by looking at a pre-existing model, where the caloric intake
was composed of: 50–60% carbohydrates, not more than 20% coming from simple sugars; a large
portion of vegetable fibers, always below than 35 g/day; between 12% and 18% of vegetable and
animal proteins; and the remaining 25–30% was provided by lipids, with just 25% of these lipids
composed of saturated fatty acids.
Each main meal should have included 1–2 portions of vegetables, fruits, and cereals, with whole
cereals preferred for grains.
Daily consumption should also have included 1–2 portions of milk and dairy products, preferably
low-fat; 3–4 portions of extra virgin olive oil, and 1–2 portions of dried fruit and seeds.
The weekly consumption of proteins should have been made up of: white meat 2–3 times per
week with just one portion of red meat per week, fish at least 2 times per week, preferably bluefish,
eggs 2–3 times per week, and legumes at least 2 times per week.
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Participants were also reminded of the importance of good hydration, with the suggestion that
they should consume 1.5–2 L of water every day, far from meals, and preferably in small amounts.
Participants were recommended not to add too much salt to their meals, to always employ simple
ways of cooking, and to avoid using butter or oil for cooking.
2.3. Bioelectrical Analysis
Unlike other techniques used to assess body composition, such as underwater weighing
(densitometry), dual energy X-ray absorptiometry (DEXA), and magnetic resonance imaging (MRI)
which are expensive, inconvenient for the participant, and not feasible to conduct in the field because
they require large specialized equipment, bioelectrical impedance analysis (BIA) is by contrast relatively
simple, quick, and non-invasive. The results are available immediately and reproducible [13].
BIA was used to assess hydration status and distribution of body water and was carried out
according to the recommendations of the National Institute of Health( NIH) Consensus Statement.
The measurements were done on the right side of the body according to the manufacturer’s
instructions [14].
In addition to (TBW) and distribution (ICW and ECW), other measures included body cellular
mass (BCM), extra cellular mass (ECM), and the phase angle (PA). BCM represents the total mass of
all cellular elements where main metabolic processes occur. In the human body, the phase angle is
used to determine intra- and extracellular quantities, which represent an important prognostic index
used to monitor the presence and evolution of chronic inflammatory processes. The use of BIA in this
setting is non-invasive, cost-effective, and provides reliable data on total body water.
2.4. Statistical Analysis
Descriptive statistics were calculated on all variables and presented as mean± standard deviation.
A repeated measures analysis of variance (ANOVA) was used to test means across time. The level of
significance was set at p < 0.05 and comparisons between T0 and T6 and between T6 and T12 were
made in order to give more information regarding modification trends. The data were analyzed using
the statistical package IBM SPSS Statistics (version 13.0) for Windows. (SPSS Inc., Chicago, IL, USA).
3. Results
All subjects completed the 12-month study protocol and no adverse events were recorded.
Body weight and BMI were unchanged over the course of the study, however, there were significant
changes in body water distribution.
A significant increase of ICW% at T6 and T12 which is related to a significant reduction of ECW%
at T6 and at T12 was observed, despite the absence of a significant variation of TBW% (see Table 1 and
Figures 1 and 2). Additionally, there were significant increases in PA and BCM at 6 and 12 months of
physical activity with concomitant decreases in ECM (Figures 3–5).
Table 1. Comparison of selected variables after 6 and 12 months of cancer rehabilitation.
n = 28 Cancer Patients T0 T6 P∆t0–t6 T12 P∆t0–t12 ANOVA Test
Weight (kg) 70.2 ± 9.9 69.9 ± 14.9 NS 70.5 ± 15.8 NS NS
BMI (kg·m−2) 26.7 ± 5.4 26.6 ± 5.6 NS 26.8 ± 5.8 NS NS
PA (◦) 5.4 ± 0.7 5.7 ± 0.8 <0.05 5.9 ± 0.7 <0.005 <0.05
FM (%) 34.6 ± 8.3 34.4 ± 8.5 NS 33.7 ± 10.3 NS NS
FFM (%) 65.4 ± 8.3 65.6 ± 8.5 NS 66.3 ± 10.3 NS NS
TBW (%) 49.2 ± 5.6 49.5 ± 6.0 NS 50.0 ± 7.0 NS NS
ECW (%) 48.9 ± 3.9 47.6 ± 4.1 <0.05 46.4 ± 3.1 <0.005 <0.05
ICW (%) 51.1 ± 3.9 52.4 ± 4.1 <0.05 53.6 ± 3.1 <0.005 <0.05
BCM (%) 50.3 ± 4.2 51.7 ± 4.4 <0.05 53.0 ± 3.4 <0.005 <0.05
ECM (%) 49.7 ± 4.2 48.3 ± 4.4 <0.05 47.0 ± 3.4 <0.005 <0.05
Legend: (BMI) Body Mass Index; (PA) Phase Angle; (FM) Fat Mass; (FFM) Free Fat Mass; (TBW) Total Body Water;
(ECW) Extra Cellular Water; (ICW) Intra Cellular Water; (BCM) Body Cellular Mass; (ECM) Extra Cellular Mass.
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Figure 1. Extra cellular water (ECW) percentage at T0, T6, and T12. Significant decreases in ECW% 
were observed at T6 and T12 in cancer patients; no significant variation in the healthy subjects group 
was observed. 
 
Figure 2. Intracellular water (ICW) percentage at T0, T6, and T12. Significant increases in ICW% were 
observed at T6 and T12 in cancer patients; no significant variation in the healthy subjects group was 
observed. 
 
Figure 3. Extracellular water mass (ECM) percentage at T0, T6, and T12. Significant decreases in 
ECM% were observed at T6 and T12 in cancer patients; no significant variation in the healthy subjects 
group was observed. 
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Figure 1. Extra cellular water (ECW) percentage at T0, T6, and T12. Significant decreases in ECW%
were observed at T6 and T12 in cancer patients; no significant variation in the healthy subjects group
was observed.
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Figure 2. Intracellular water (ICW) percentage at T0, T6, and T12. Significant increases in ICW%
were observed at T6 and T12 in cancer patients; no significant variation in the healthy subjects group
was observed.
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Figure 3. Extracellular water mass (ECM) percentage at T0, T6, and T12. Significant decreases in ECM%
were observed at T6 and T12 in cancer patients; no significant variation in the healthy subjects group
was observed.
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Figure 4. Body cellular mass (BCM) percentage at T0, T6, and T12. Significant increases in BCM%
were observed at T6 and T12 in cancer patients; no significant variation in the healthy subjects group
was observed.
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In the group of active healthy subjects, there were no significant changes observed in the follow-up
at 6 and 12 months in regard to the intra and extra cellular hydration, while there was a significant
increase in TBW% at 6 months (see Table 2).
Table 2. Comparison of selected variables after 6 and 12 months of physical activity program.
n = 23 Healthy Subjects T0 T6 P∆t0–t6 T12 P∆t0–t12 ANOVA Test
Weight (kg) 76.6 ± 12.3 76.0 ± 11.6 NS 75.6 ± 11.4 NS NS
BMI 26.1 ± 2.8 25.8 ± 2.4 NS 25.6 ± 2.5 NS NS
PA (◦) 5.9 ± 0.9 6.0 ± 0.9 NS 6.0 ± 0.9 NS NS
FM (%) 28.8 ± 5.4 27.5 ± 6.4 <0.05 28.0 ± 5.4 NS NS
FFM (%) 71.2 ± 5.4 72.5 ± 6.4 <0.05 72.0 ± 5.4 NS NS
TBW ( ) 53.0 ± 4.4 54.1 ± 5.0 <0.05 53.7 ± 4.3 NS NS
ECW (%) 46.3 ± 4.2 45.8 ± 3.9 NS 45.8 ± 4.6 NS NS
ICW (%) 53.7 ± 4.2 54.2 ± 3.9 NS 54.2 ± 4.6 NS NS
BCM (%) 53.2 ± 4.5 53.6 ± 4.3 NS 53.6 ± 5.0 NS NS
ECM (%) 46.8 ± 4.5 46.4 ± 4.3 NS 46.4 ± 5.0 NS NS
Legend: (BMI) Body Mass Index; (PA) Phase Angle; (FM) Fat Mass; (FFM) Free Fat Mass; (TBW) Total Body Water;
(ECW) Extra Cellular Water; (ICW) Intra Cellular Water; (BCM) Body Cellular Mass; (ECM) Extra Cellular Mass.
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4. Discussion
Many metabolic chronic diseases including cancer are associated with abnormal water
distribution [14,15]. Proper hydration balance is an important medical consideration, as abnormal
TBW status and distribution can increase the risk of cardiovascular pathologies including
thrombogenesis. Additionally, it has also been shown that impaired hydration status can have
a negative impact on overall survival, even in healthy people [16,17]. Therefore, it is critical to monitor
and adjust abnormalities in TBW and water distribution. It was the goal of this study to see if TBW and
distribution could be altered with a home-based rehabilitation program consisting of unsupervised
aerobic and resistance training in a breast cancer group.
In this study, regular moderate physical activity, which is typically prescribed to increase
cardiorespiratory fitness and strength, was used as a stimulus to activate skeletal muscle, which assisted
in a redistribution of TBW to a more clinically stable standard. This is an important component of
the cancer rehabilitation program, as it may help increase skeletal muscle performance and indirectly
decrease the risk of musculoskeletal damage [18].
Several methods have been used to assess and quantify hydration status. The non-invasive
method of BIA used in this study proved to be a reliable and effective approach to monitor tissue
body water in breast cancer patients and is similar to data presented elsewhere [19]. Additionally,
the data from this study demonstrate BIA was sensitive enough to detect fluid shifts after a moderate
physical activity program that was independent of body weight changes. The progressive fluid shift
from intracellular to extracellular compartments seen by positive phase angle changes in this study is
similar to the mechanism by which the exercise is used to reduce edema.
Lastly, the results of this study also provide supporting evidence that physical activity adherence
can be high when using phone call-initiated follow ups and that a home-based rehabilitation program
was effective in modifying tissue water distribution [20].
5. Conclusions
Hydration status, in the dynamic concept of body fluid distribution, is one of the principal
components related to the survival of diseased patients. Given that hydration in advanced cancer is
poorly understood, it is important to advance the assessment of hydration in this group. By using
physical activity as a therapeutic post-cancer treatment, not only can functionality and quality of life
be improved, but tissue water distribution can be restored, thereby further improving physiologic
function and overall health.
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